Larvol Delta - ASLAN-Pharmaceuticals-Announces-Completion-of-Recruitment-in-Phase-2b-TREKAD-Study-of-Eblasakimab-in-Atopic-Dermatitis-Patients

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2023/02/24/2615064/0/en/ASLAN-Pharmaceuticals-Announces-Completion-of-Recruitment-in-Phase-2b-TREK-AD-Study-of-Eblasakimab-in-Atopic-Dermatitis-Patients.html

Feb 24, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next